Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IFN-induced depression: a role for NSAIDs.

Gregory M Asnis1, Richard De La Garza, Shari R Kohn

  • 1Department of Internal Medicine, Yeshiva University's Albert Einstein College of Medicine, and Anxiety and Depression Program, Montifiore Medical Center, Bronx, NY, USA. asnisarts@aol.com

Psychopharmacology Bulletin
|November 11, 2003
PubMed
Summary

Non-steroidal anti-inflammatory drugs (NSAIDs) may prevent interferon-alpha (IFN)-induced depression. This research explores NSAIDs as a potential treatment for IFN-related neuropsychiatric side effects, offering an alternative to conventional antidepressants.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing data-driven health research from the <i>All of Us</i> data training and engagement program.

Journal of the Medical Library Association : JMLA·2026
Same author

IDH1 R132 mutations or HER2-positivity and benefit from platinum-based therapy for biliary tract cancers.

JHEP reports : innovation in hepatology·2026
Same author

Adjunctive Cannabidiol in Inpatient Buprenorphine Treatment for Opioid Use Disorder: A Pilot Randomized Trial.

Journal of addiction medicine·2025
Same author

Assessing Grief in Cancer Care: A Systematic Review of Observational Studies Using Psychometric Instruments.

Healthcare (Basel, Switzerland)·2025
Same author

Immune and neural response to acute social stress in adolescent humans and rodents.

Translational psychiatry·2024
Same author

The effect of the COVID-19 pandemic on substance use patterns and physiological dysregulation in pregnant and postpartum women.

Alcohol, clinical & experimental research·2023

Area of Science:

  • Neuroscience
  • Pharmacology
  • Immunology

Background:

  • Interferon-alpha (IFN) treats viral and chronic diseases but causes significant neuropsychiatric side effects, including depression.
  • Conventional antidepressants show limited efficacy in preventing IFN-induced depression, necessitating alternative therapeutic strategies.

Purpose of the Study:

  • To investigate the potential of non-steroidal anti-inflammatory drugs (NSAIDs) in preventing or reducing interferon-alpha (IFN)-induced depression.
  • To explore NSAIDs as an alternative treatment for IFN-induced neuropsychiatric symptoms.

Main Methods:

  • Review of pre-clinical and clinical research on NSAIDs and IFN side effects.
  • Analysis of NSAIDs' known effects on cytokine activation, stress hormone release, and neurochemical alterations.

Related Experiment Videos

Main Results:

  • NSAIDs counteract several IFN-induced side effects, including cytokine activation and reduced serotonin levels.
  • NSAIDs are effective for flu-like symptoms and premenstrual dysphoric disorder, suggesting a role in depression.

Conclusions:

  • Pretreatment with NSAIDs is hypothesized to reduce flu-like symptoms and prevent or alleviate IFN-induced depression.
  • NSAIDs represent a promising therapeutic avenue for managing IFN-associated depressive disorders.